Next-generation medical nanorobotics: biohybrid systems, AI-guided navigation, and clinical translation challenges

Medical nanorobotics advances nanomedicine by integrating nanotechnology and intelligence into active platforms capable of performing active navigation, real-time monitoring, and controlled therapeutic payload release. This review discusses the design approaches for targeted drug delivery, compares nanorobots with other nanomaterials and traditional nanomedicine, and examines the translational, regulatory, and production challenges associated with their clinical implementation. This review evaluates the architecture of nanorobots, including sensors, actuators, payloads, propellers, power sources, and communication systems. It discusses propulsion mechanisms based on endogenous chemical/enzymatic and exogenous magnetic, electrical, light, and ultrasound stimuli. It also examines fabrication techniques such as roll-up/self-winding, Physical Vapor Deposition, laser direct writing/3D printing, two-photon lithography, template-assisted electrodeposition, self-assembly, and wet chemical synthesis. Compared with conventional nanomaterials, nanorobots have demonstrated enhanced targeting capability, adaptive behavior, and multifunctional operation in preclinical models through guided or semi-autonomous navigation and feedback-controlled drug release. Although promising applications have been reported for cancers, cardiovascular diseases, inflammatory disorders, neurological conditions, ophthalmic diseases, tissue engineering, and dentistry, most systems remain in the preclinical stage owing to challenges such as Brownian motion, limited energy availability, immune clearance, biocompatibility concerns, scalability issues and the lack of established regulatory frameworks. Overall, medical nanorobots represent a promising strategy for precision medicine and targeted drug delivery; however, overcoming biological, technological, manufacturing, and regulatory barriers is essential for successful clinical translation.

Authors

Institutions

Publication Details

Journal
Next Nanotechnology
Published
2026-10-16
DOI
https://doi.org/10.1016/j.nxnano.2026.100824
Primary Topic
Micro and Nano Robotics
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Next-generation medical nanorobotics: biohybrid systems, AI-guided navigation, and clinical translation challenges

Dharmendra Jain, Vandana Soni, Asmita Gajbhiye, Amit Pratap Singh et al.
Next Nanotechnology
Micro and Nano Robotics
article

Next-generation medical nanorobotics: biohybrid systems, AI-guided navigation, and clinical translation challenges

Dharmendra Jain, Vandana Soni, Asmita Gajbhiye, Amit Pratap Singh, Ayushi Gupta
article en

Abstract

Medical nanorobotics advances nanomedicine by integrating nanotechnology and intelligence into active platforms capable of performing active navigation, real-time monitoring, and controlled therapeutic payload release. This review discusses the design approaches for targeted drug delivery, compares nanorobots with other nanomaterials and traditional nanomedicine, and examines the translational, regulatory, and production challenges associated with their clinical implementation. This review evaluates the architecture of nanorobots, including sensors, actuators, payloads, propellers, power sources, and communication systems. It discusses propulsion mechanisms based on endogenous chemical/enzymatic and exogenous magnetic, electrical, light, and ultrasound stimuli. It also examines fabrication techniques such as roll-up/self-winding, Physical Vapor Deposition, laser direct writing/3D printing, two-photon lithography, template-assisted electrodeposition, self-assembly, and wet chemical synthesis. Compared with conventional nanomaterials, nanorobots have demonstrated enhanced targeting capability, adaptive behavior, and multifunctional operation in preclinical models through guided or semi-autonomous navigation and feedback-controlled drug release. Although promising applications have been reported for cancers, cardiovascular diseases, inflammatory disorders, neurological conditions, ophthalmic diseases, tissue engineering, and dentistry, most systems remain in the preclinical stage owing to challenges such as Brownian motion, limited energy availability, immune clearance, biocompatibility concerns, scalability issues and the lack of established regulatory frameworks. Overall, medical nanorobots represent a promising strategy for precision medicine and targeted drug delivery; however, overcoming biological, technological, manufacturing, and regulatory barriers is essential for successful clinical translation.

Next NanotechnologyVol. 10
Dr. Hari Singh Gour University (IN)
Good health and well-being
Openalex Percentile: Top 22%
Micro and Nano Robotics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.